Panel Discussion: Pharma’s Perspective on Search & Discovery in Pain Therapeutics

• What is the industry looking for in terms of novel pain therapies?
• Target prioritization for pharma between NaV channels and emerging novel targets
• The importance of having pre-clinical data beyond animal studies to validate novel pain targets
• Utilizing human biology data sets to help determine the translational potential

Speakers:

Asli Sahin

Director Search & Evaluation

Abbvie

Darrell Henze

Executive Director

Merck & Co

Chris Adams

Executive Director Search & Evaluation

Novartis

John Markman

Vice President Global Pain

Eli Lilly & Co.